Detailed answers about BASET FOR PHARMACEUTICALS LIMITED, including incorporation, status, business activity, and accounts information.
When was BASET FOR PHARMACEUTICALS LIMITED founded?
BASET FOR PHARMACEUTICALS LIMITED was officially incorporated on 13 January 2025 and is registered under company number 16178465. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BASET FOR PHARMACEUTICALS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BASET FOR PHARMACEUTICALS LIMITED?
BASET FOR PHARMACEUTICALS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BASET FOR PHARMACEUTICALS LIMITED do?
BASET FOR PHARMACEUTICALS LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering, 86102 - Medical nursing home activities. These SIC codes provide insight into the company's business activities and industry focus.
What is BASET FOR PHARMACEUTICALS LIMITED's registered address?
The registered office address of BASET FOR PHARMACEUTICALS LIMITED is 73-75 ALDGATE HIGH STREET, LONDON, ENGLAND, EC3N 1BD. This is the official address filed with Companies House for legal and statutory correspondence.
Is BASET FOR PHARMACEUTICALS LIMITED financially stable?
Financial accounts for BASET FOR PHARMACEUTICALS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.